Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Option Care Health

OPCH Healthcare Unknown Updated July 31, 2026
$23.03
52W $18.01 – $36.80
59/100
$3.62B
17.3
0.65
AI Committee Verdict
Watch
Conviction: Contested · 50% agreement · 6 analysts
+5.4%
-0.1%
59.78:1
Contested

Is OPCH Bullish or Bearish?

Mixed. Innellis AI committee rates Option Care Health (OPCH) Watch with a composite score of 59/100 , based on 6 analysts with 50% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +1.19 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -18.81 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull & Bear Case

Bull Case
  • ROE of 15.3% shows genuine earnings power backing the valuation — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.27 across 19 articles, 14d) — News
Bear Case
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
59/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 17%
of 93 Healthcare peers
Value Analyst bullish
63 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ ROE of 15.3% shows genuine earnings power backing the valuation
Growth Analyst bullish
62 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 19 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 58.4 to 58.8.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • News Analyst: +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).
  • Technical Analyst: score 48->58 (+10).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
60.8
Neutral
MACD Histogram
0.168
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$23.01
Resistance
$24.27
Bollinger %B
0.93
Inside Bands
Price vs Moving Averages
EMA 9
$22.40 Above
EMA 21
$22.00 Above
EMA 50
$22.22 Above
EMA 200
$26.09 Below

Fundamental Analysis

Valuation
57
Growth
68
Profitability
0
Financial Health
65
Cash Flow
38
Valuation
P/E Ratio 17.3×
P/B Ratio 2.83×
PEG Ratio 3.67
Dividend Yield 0.00%
52W High $36.80
52W Low $18.01
Quality & Growth
ROE 15.7%
ROA 6.0%
Gross Margin 18.2%
Operating Margin 5.9%
Revenue Growth YoY
Debt / Equity 1.01
AI Fundamental Assessment
P/E ratio of 17.3 (inexpensive relative to a 15-40x range); Price-to-book of 2.8x; PEG ratio of 3.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.0%; Gross margin of 0.2%; Current ratio of 1.47 (tight short-term liquidity); Debt-to-equity of 1.01; Free cash flow margin of 1.0% (thin cash generation); Free cash flow per share is positive (2.24); Most recent quarter beat estimates by 3.2%; 2 consecutive earnings beats; EPS growth accelerating (-13.0% -> +12.5% QoQ); Average YoY EPS growth of 9.8%; Analyst estimates falling over recent quarters
Get the Full OPCH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore OPCH Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime